Riley_2009_IDrugs_12_648

Reference

Title : Darapladib, a reversible lipoprotein-associated phospholipase A2 inhibitor, for the oral treatment of atherosclerosis and coronary artery disease - Riley_2009_IDrugs_12_648
Author(s) : Riley RF , Corson MA
Ref : IDrugs , 12 :648 , 2009
Abstract : Riley_2009_IDrugs_12_648
ESTHER : Riley_2009_IDrugs_12_648
PubMedSearch : Riley_2009_IDrugs_12_648
PubMedID: 19790016

Related information

Citations formats

Riley RF, Corson MA (2009)
Darapladib, a reversible lipoprotein-associated phospholipase A2 inhibitor, for the oral treatment of atherosclerosis and coronary artery disease
IDrugs 12 :648

Riley RF, Corson MA (2009)
IDrugs 12 :648